Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NVS [NYSE]
Novartis AG
Index- P/E24.78 EPS (ttm)3.79 Insider Own- Shs Outstand2.73B Perf Week0.15%
Market Cap255.92B Forward P/E16.51 EPS next Y5.69 Insider Trans- Shs Float412.76M Perf Month5.98%
Income9.38B PEG2.99 EPS next Q1.30 Inst Own9.80% Short Float0.42% Perf Quarter3.21%
Sales56.90B P/S4.50 EPS this Y-2.40% Inst Trans-0.02% Short Ratio1.56 Perf Half Y14.89%
Book/sh28.89 P/B3.25 EPS next Y10.23% ROA7.80% Target Price95.74 Perf Year27.53%
Cash/sh2.69 P/C34.89 EPS next 5Y8.30% ROE13.60% 52W Range70.40 - 95.50 Perf YTD20.76%
Dividend2.72 P/FCF- EPS past 5Y0.80% ROI10.20% 52W High-1.17% Beta0.51
Dividend %2.90% Quick Ratio1.00 Sales past 5Y6.70% Gross Margin67.10% 52W Low34.06% ATR0.91
Employees135000 Current Ratio1.30 Sales Q/Q5.00% Oper. Margin20.80% RSI (14)65.30 Volatility0.81% 0.68%
OptionableYes Debt/Eq0.29 EPS Q/Q5.80% Profit Margin17.10% Rel Volume1.09 Prev Close93.90
ShortableYes LT Debt/Eq0.18 EarningsApr 19 Payout60.70% Avg Volume1.11M Price94.38
Recom2.20 SMA201.86% SMA505.11% SMA20011.34% Volume125,046 Change0.51%
16-Nov-09Initiated Deutsche Securities Buy
12-Nov-09Initiated Barclays Capital Underweight $48
30-Sep-09Upgrade Citigroup Hold → Buy
15-Sep-09Upgrade Jefferies & Co Hold → Buy
17-Jul-09Upgrade JP Morgan Neutral → Overweight
17-Mar-09Initiated Credit Suisse Neutral
27-Feb-09Reiterated Credit Suisse Neutral $14 → $7
26-Jan-09Initiated Jefferies & Co Hold
23-Sep-08Upgrade Credit Suisse Underperform → Neutral
06-Aug-08Downgrade JP Morgan Overweight → Neutral
12-Jun-08Downgrade HSBC Securities Neutral → Underweight $52 → $49
04-Jun-08Upgrade Cowen & Co Neutral → Outperform
09-May-08Upgrade Bernstein Mkt Perform → Outperform
08-Apr-08Downgrade Bear Stearns Outperform → Peer Perform
29-Feb-08Initiated Cowen & Co Neutral
29-Feb-08Downgrade HSBC Securities Neutral → Underweight
06-Sep-07Initiated UBS Buy
18-Jul-07Downgrade Credit Suisse Neutral → Underperform
01-Jun-07Reiterated Prudential Overweight $64 → $62
02-Apr-07Reiterated Banc of America Sec Buy $66 → $65
18-Sep-14 12:54PM  IPO Stock Watch: Biotech ProQR Rises In IPO Debut at Investor's Business Daily
17-Sep-14 05:12PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
16-Sep-14 05:10PM  Roche Starts Trials on Lampalizumab for Geographic Atrophy Zacks
06:35AM  Ebola under the microscope CNBC
06:35AM  [video] Ebola under the microscope at CNBC
15-Sep-14 04:35PM  Novartis Presents Positive Data on Lucentis and Jetrea Zacks
14-Sep-14 04:34PM  3 Companies Investing In Stem Cell Research Benzinga
11-Sep-14 04:55PM  Novartis Presents Data on Multiple Sclerosis Drug Gilenya Zacks
10-Sep-14 11:58AM  ReceptosMS Drug Yields More Good Data; Stock Jumps at Investor's Business Daily
11:58AM  Receptos MS Drug Yields More Good Data; Stock Jumps at Investor's Business Daily
08-Sep-14 04:05PM  Novartis (NVS) Presents Positive Data on Ultibro Breezhaler Zacks
05-Sep-14 07:00AM  Blockbusters Differentiate Novartis Morningstar
06:30AM  Novartis Offers Healthy Gains at a Bargain Stock Price at TheStreet
04-Sep-14 01:00PM  Why are Irelands labor markets more flexible than Spains? Market Realist
03-Sep-14 05:41PM  The Market's Roses, Thorns, and All Time Highs... Yahoo Finance Blogs
02-Sep-14 06:35PM  2014 Jackson Hole Symposium revaluates labor market dynamics Market Realist
06:04PM  Novartis, Regeneron Shares Advance To New Highs On Updated Drug News Investor's Business Daily
05:39PM  Today's Thorns, Roses and All Time Highs in the Markets... Yahoo Finance Blogs
05:25PM  United Therapeutics Soars on Remodulin Patent Case Win Zacks
04:10PM  Novartis Releases Positive Data on LCZ696 for Heart Failure Zacks
04:02PM  [$$] Blockbuster Expectations for Novartis' Heart Drug at Barrons.com
02:17PM  [$$] Blockbuster Expectations for Novartis' Heart Drug at Barrons.com
11:19AM  Novartis, Regeneron Hit New Highs On Cardio Drugs at Investor's Business Daily
10:19AM  Why Novartis AG (NVS) Stock Is Climbing Today at TheStreet
08:17AM  Novartis' Game Changer: When Failure Turns To Success at Forbes
01-Sep-14 11:08AM  Heart Drug Study Gives Novartis a Shot in the Arm at The Wall Street Journal
03:27AM  Novartis Rises Most in Five Months on Heart-Drug Trial at Bloomberg
31-Aug-14 12:37PM  Heart drug launch could be "most exciting ever", says Novartis Reuters
30-Aug-14 12:21PM  Novartis' investigational heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in PARADIGM-HF trial CNW Group
11:42AM  Study: Novel heart failure drug shows big promise at USA TODAY
07:38AM  [$$] Novartis Data Show Heart Drug Beats Rival at The Wall Street Journal
07:03AM  Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial PR Newswire
07:00AM  New Novartis Drug Effective in Treating Heart Failure at New York Times
07:00AM  Novartis Heart Failure Drug Tops Standard in Study at Bloomberg
27-Aug-14 10:00AM  Predicting PARADIGM-HF, Or What To Expect When You're Expecting at Forbes
25-Aug-14 05:50PM  [video] A sensor to swallow with your medicine at CNBC
20-Aug-14 05:13PM  Novartis to Invest $35M in Gamida Cell for 15% Equity Zacks
19-Aug-14 08:28AM  Why Novartis (NVS) Stock Is Gaining Today at TheStreet
05:33AM  Novartis to invest in Israel's Gamida Cell, could buy out company Reuters
15-Aug-14 10:13AM  Digital Transformation Moves Pharma 'Beyond the Pill' at Forbes
10:13AM  Digital Transformation Moves Pharma "Beyond the Pill" at Forbes
14-Aug-14 08:33PM  [video] Eyeball injections equal eye-popping profits at CNNMoney.com
13-Aug-14 11:31AM  Cancer: Unpronounceable Drugs, Incomprehensible Prices at Forbes
08-Aug-14 08:18AM  Even At $900 (Vs. $84,000 In US) Hep C Cure Sovaldi's Cost Could Be Unacceptable In India at Forbes
07-Aug-14 08:27PM  Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Reuters
06-Aug-14 09:50AM  QLT Q2 Loss Widens, Focus on Impending Merger with Auxilium Zacks
01-Aug-14 08:47AM  GlaxoSmithKline LLC -- Moody's downgrades GlaxoSmithKline to A2, outlook stable at Moody's
30-Jul-14 05:00PM  Novartis Malaria Pill Shows Promise as Best Drugs Fail at Bloomberg
28-Jul-14 05:30PM  Novartis Division Gets European Approval for Simbrinza Zacks
25-Jul-14 11:40AM  Trade like a congressman as OpenSecrets launches stock-trading database at MarketWatch
24-Jul-14 04:32PM  Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure? at Motley Fool
03:41PM  FDA reviewing what could be first biosimilar drug AP
23-Jul-14 06:17PM  Biogen, Gilead Earnings Crush Q2 Estimates Investor's Business Daily
04:32PM  Biogen Stock's Tecfidera Embarrasses Wall Street at Motley Fool
02:02PM  5 Novartis Drugs You Need To Know About at Motley Fool
11:56AM  Biogen Trounces Q2 Estimates As Tecfidera Outperforms at Investor's Business Daily
11:37AM  Biogen Trounces Q2 Estimates As Tecfidera Outperforms at Investor's Business Daily
08:45AM  Top Biotechnology Stocks Accesswire
22-Jul-14 04:08PM  These Might Be the Worst Ideas for Google Wearables at Motley Fool
04:05PM  Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. Zacks
21-Jul-14 09:53AM  3 Household-Name Stocks With Dividend Yields Over 3% And P/E Ratios Under 15 at Seeking Alpha
09:08AM  Mondays Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech at Motley Fool
19-Jul-14 08:16AM  Why Does Novartis Want Googles "Smart" Contact Lens? at Motley Fool
18-Jul-14 01:10PM  5 New Medical Technologies For Diabetics Benzinga
11:50AM  Novartis Misses on Q2 Earnings & Revenue, Outlook Retained Zacks
10:38AM  Update: Google Teaming Up With Novartis To Develop Smart Lenses at Seeking Alpha
09:59AM  Novartis Joins Google To Develop Contacts For Diabetics Benzinga
01:05AM  [$$] Novartis Profit Creeps Higher Ahead of Revamp at The Wall Street Journal
12:01AM  [$$] Novartis Profit Creeps Higher Ahead of Revamp at The Wall Street Journal
17-Jul-14 11:08PM  [$$] Novartis Profit Creeps Higher Ahead of Revamp at The Wall Street Journal
09:19PM  [$$] Novartis Profit Creeps Higher Ahead of Revamp at The Wall Street Journal
03:26PM  Forget Earnings: Catalysts Incoming for Novartis Stock at Motley Fool
03:20PM  Why Novartis (NVS) Stock Is Down Today at TheStreet
11:12AM  Alzheimer's Rates Falling, But Pharma's Search For a Cure Yields No Results Benzinga
08:45AM  3 Top Stocks to Watch on Earnings: Baxter International, Novartis and UnitedHealth Group at Motley Fool
07:34AM  Novartis maintains forecasts despite weak quarter at Financial Times
07:33AM  Novartis Splits the Difference at The Wall Street Journal
06:38AM  [$$] Novartis Profit Creeps Higher Ahead of Revamp at The Wall Street Journal
05:58AM  [$$] Novartis Profit Creeps Higher Ahead of Revamp at The Wall Street Journal
05:42AM  [video] Novartis Misses Estimates as Vaccine Unit Slumps at Bloomberg
04:42AM  Novartis cites momentum in 3 percent profit rise AP
04:26AM  Drugmaker Novartis to eke out more cost savings to lift margins Reuters
02:35AM  [$$] Novartis Profit Lifted by Emerging Markets at The Wall Street Journal
02:31AM  Novartis cites momentum in 3 percent profit rise AP
01:56AM  [$$] Novartis Profit Lifted by Emerging Markets at The Wall Street Journal
01:13AM  Novartis Profit Misses Estimates; Forecast Confirmed at Bloomberg
16-Jul-14 11:31AM  Novartis Jumps Onboard Googles Smart Contact Lens Project at Wall St. Cheat Sheet
07:47AM  5 Novartis Questions We Need Answered at Motley Fool
15-Jul-14 09:25PM  [$$] Novartis and Google to Work on Smart Contact Lenses at The Wall Street Journal
07:15PM  Google's X division Investor's Business Daily
04:10PM  Google, Novartis join to develop smart contact lens at San Jose Mercury News
04:10PM  Novartis, Google to Develop Contact Lenses to Monitor Blood Sugar Entrepreneur
03:14PM  Google partners with Novartis to create smart contact lens at Los Angeles Times
12:42PM  Novartis and Google to develop 'smart' contact lens Reuters
12:22PM  Will Novartis (NVS) Stock Be Helped By Google (GOOG) 'Smart' Contact Lens Agreement? at TheStreet
12:13PM  [$$] Novartis, Google Team Up on Lenses at The Wall Street Journal
11:51AM  [$$] Novartis, Google Team Up on Lenses at The Wall Street Journal
11:24AM  [$$] Novartis, Google Team Up on Lenses at The Wall Street Journal
11:11AM  Google smart contact lenses could be revolutionary Hot Stock Minute
09:41AM  Novartis Joins With Google to Develop Contact Lens to Monitor Blood Sugar at New York Times
Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines. Its Consumer Health division offers over-the-counter medicines comprising readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. The company distributes its OTC products through various channels, such as food, drug, and mass retail outlets, as well as pharmacies; and Animal Health products directly and through wholesalers of veterinary products. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.